共 122 条
- [1] Kapoor KG(2015)The sustained-release dexamethasone implant: expanding indications in vitreoretinal disease Semin Ophthalmol 30 475-481
- [2] Wagner MG(2011)The dexamethasone drug delivery system: indications and evidence Adv Ther 28 351-366
- [3] Wagner AL(2007)Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis J Control Release 117 68-79
- [4] London NJ(2012)Dexamethasone enhances oxidative stress-induced cell death in murine neural stem cells Neurotox Res 22 127-3724
- [5] Chiang A(2002)Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species Inflammation 26 215-222
- [6] Haller JA(2006)In-vitro effects of dexamethasone on cellular proliferation, apoptosis, and Na+-K+-ATPase activity of bovine corneal endothelial cells Ocul Immunol Inflamm 14 215-223
- [7] Patil SD(2000)Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues Invest Ophthalmol Vis Sci 41 1629-1638
- [8] Papadmitrakopoulos F(1992)Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection Arch Ophthalmol 110 259-266
- [9] Burgess DJ(2015)Effect of intravitreal injection of dexamethasone implant on corneal endothelium in macular edema due to retinal vein occlusion Cutan Ocul Toxicol 34 294-297
- [10] Mutsaers HA(2010)Retinal vein thrombosis: pathogenesis and managment J Thromb Haemost 8 1886-1894